Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_assertion type Assertion NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_head.
- NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_provenance.
- NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_assertion evidence source_evidence_literature NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_provenance.
- NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_assertion SIO_000772 7923570 NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_provenance.
- NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_assertion wasDerivedFrom befree-20140225 NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_provenance.
- NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_assertion wasGeneratedBy ECO_0000203 NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_provenance.